|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verdoodt F, Kjaer Hansen M, Kjaer SK,
Pottegård A, Friis S and Dehlendorff C: Statin use and mortality
among ovarian cancer patients: A population-based cohort study. Int
J Cancer. 141:279–286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Braga SFM, de Souza MC and Cherchiglia ML:
Time trends for prostate cancer mortality in Brazil and its
geographic regions: An age-period-cohort analysis. Cancer
Epidemiol. 50:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coppedè F: Epigenetic biomarkers of
colorectal cancer: Focus on DNA methylation. Cancer Lett.
342:238–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCleary-Wheeler AL, Lomberk GA, Weiss FU,
Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna
JL, Ellenrieder V, et al: Insights into the epigenetic mechanisms
controlling pancreatic carcinogenesis. Cancer Lett. 328:212–221.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu MM, Lee CH, Hsu LI, Cheng WF, Lee TC,
Wang YH, Chiou HY and Chen CJ: Effect of heme oxygenase-1 gene
promoter polymorphism on cancer risk by histological subtype: A
prospective study in arseniasis-endemic areas in Taiwan. Int J
Cancer. 138:1875–1886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ghadban T, Miro JT, Trump F, Tsui TY,
Uzunoglu FG, Reeh M, Gebauer F, Bachmann K, Wellner U, Kalinin V,
et al: Diverse prognostic value of the GTn promoter polymorphism in
squamous cell and adeno carcinoma of the oesophagus. Clin Genet.
90:343–350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dunn LL, Midwinter RG, Ni J, Hamid HA,
Parish CR and Stocker R: New insights into intracellular locations
and functions of heme oxygenase-1. Antioxid Redox Signal.
20:1723–1742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang MM, Zheng YY, Gao Y, Zhang JZ, Liu
F, Yang YN, Li XM, Ma YT and Xie X: Heme oxygenase-1 gene promoter
polymorphisms are associated with coronary heart disease and
restenosis after percutaneous coronary intervention: A
meta-analysis. Oncotarget. 7:83437–83450. 2016.PubMed/NCBI
|
|
11
|
Luo H, Li Z, Qing Y, Zhang SH, Peng Y, Li
Q and Wang D: Single nucleotide polymorphisms of DNA base-excision
repair genes (APE1, OGG1 and XRCC1) associated with breast cancer
risk in a Chinese population. Asian Pac J Cancer Prev.
15:1133–1140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami A, Fujimori Y, Yoshikawa Y,
Yamada S, Tamura K, Hirayama N, Terada T, Kuribayashi K, Tabata C,
Fukuoka K, et al: Heme oxygenase-1 promoter polymorphism is
associated with risk of malignant mesothelioma. Lung. 190:333–337.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kikuchi A, Yamaya M, Suzuki S, Yasuda H,
Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, et
al: Association of susceptibility to the development of lung
adenocarcinoma with the heme oxygenase-1 gene promoter
polymorphism. Hum Genet. 116:354–360. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andersen V, Christensen J, Overvad K,
Tjønneland A and Vogel U: Heme oxygenase-1 polymorphism is not
associated with risk of colorectal cancer: A Danish prospective
study. Eur J Gastroenterol Hepatol. 23:282–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuwano A, Ikeda H, Takeda K, Nakai H,
Kondo I and Shibahara S: Mapping of the human gene for inducible
heme oxygenase to chromosome 22q12. Tohoku J Exp Med. 172:389–392.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang KW, Lee TC, Yeh WI, Chung MY, Liu
CJ, Chi LY and Lin SC: Polymorphism in heme oxygenase-1 (HO-1)
promoter is related to the risk of oral squamous cell carcinoma
occurring on male areca chewers. Br J Cancer. 91:1551–1555. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okamoto I, Krögler J, Endler G, Kaufmann
S, Mustafa S, Exner M, Mannhalter C, Wagner O and Pehamberger H: A
microsatellite polymorphism in the heme oxygenase-1 gene promoter
is associated with risk for melanoma. Int J Cancer. 119:1312–1315.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo SS, Lin SC, Wu CW, Chen JH, Yeh WI,
Chung MY and Lui WY: Heme oxygenase-1 gene promoter polymorphism is
associated with risk of gastric adenocarcinoma and lymphovascular
tumor invasion. Ann Surg Oncol. 14:2250–2256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong CC, Ambrosone CB, Ahn J, Choi JY,
McCullough ML, Stevens VL, Rodriguez C, Thun MJ and Calle EE:
Genetic variability in iron-related oxidative stress pathways
(Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of
postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev.
16:1784–1794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sawa T, Mounawar M, Tatemichi M, Gilibert
I, Katoh T and Ohshima H: Increased risk of gastric cancer in
Japanese subjects is associated with microsatellite polymorphisms
in the heme oxygenase-1 and the inducible nitric oxide synthase
gene promoters. Cancer Lett. 269:78–84. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu JL, Li ZY, Liu W, Zhang RG, Li GL, Wang
T, Ren JH and Wu G: Polymorphism in heme oxygenase-1 (HO-1)
promoter and alcohol are related to the risk of esophageal squamous
cell carcinoma on Chinese males. Neoplasma. 57:86–92. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XW, Wang JN, Wang AL, et al:
Association study between the risk of esophageal squamous cell
carcinoma and microsatellite polymorphism in promoter of heme
oxygenase-1. Hebei Mediacl J. 5:668–670. 2014.
|
|
23
|
Hu B, Zhang J, Wang J, Zhu C, Chen B, Kong
M, Zhang B and Zhu M: The risk of esophageal squamous cell
carcinoma associated with microsatellite polymorphism in promoter
of heme oxygenase-1. Zhonghua Wai Ke Za Zhi. 53:206–210. 2015.(In
Chinese). PubMed/NCBI
|
|
24
|
Andersen V, Kopp TI, Tjønneland A and
Vogel U: No association between HMOX1 and risk of colorectal cancer
and no interaction with diet and lifestyle factors in a prospective
Danish case-cohort study. Int J Mol Sci. 16:1375–1384. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsu LI, Wu MM, Wang YH, Lee CY, Yang TY,
Hsiao BY and Chen CJ: Association of environmental arsenic
exposure, genetic polymorphisms of susceptible genes, and skin
cancers in Taiwan. BioMed Res Int. 2015:8925792015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Motovali-Bashi M and Hamidy M: Association
between GT-repeat polymorphism at heme oxygenase-1 gene promoter
and gastric cancer and metastasis. Tumour Biol. 36:4757–4762. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang D, Tang WJ, Shi XL, Li WP, Zhou H, Lu
LM and Tao L: Association of the microsatellite (GT)n repeat
polymorphisms of the HO-1 gene promoter and corresponding serum
levels with the risk of laryngeal squamous cell carcinoma. Acta
Otolaryngol. 136:806–811. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song LY: Association of heme oxygenase-1
polymorphisms with hepatitis B-related liver disease. Guangxi Med
Univ. 24:111–120. 2015.
|
|
29
|
Jirásková A, Novotný J, Novotný L, Vodicka
P, Pardini B, Naccarati A, Schwertner HA, Hubácek JA, Puncochárová
L, Šmerhovský Z, et al: Association of serum bilirubin and promoter
variations in HMOX1 and UGT1A1 genes with sporadic colorectal
cancer. Int J Cancer. 131:1549–1555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Song FF, Huang YB, Zheng H, Song
FJ and Chen KX: Association between the (GT)n polymorphism of the
HO-1 gene promoter region and cancer risk: A meta-analysis. Asian
Pac J Cancer Prev. 15:4617–4622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo H, Shao Y, Yao N, Chen X, Hu L and He
T: Association of heme oxygenase-1 polymorphisms with cancer risk:
A systematic review and meta-analysis. J BUON. 20:1142–1153.
2015.PubMed/NCBI
|
|
32
|
Moher D, Liberati A, Tetzlaff J and Altman
D: Reviews and Meta-Analyses: The PRISMA statement reprint -
Preferred reporting items for systematic. Phys Ther. 89:873–880.
2009.PubMed/NCBI
|
|
33
|
Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW
and Chang CS: Functional polymorphism in NFKB1 promoter is related
to the risks of oral squamous cell carcinoma occurring on older
male areca (betel) chewers. Cancer Lett. 243:47–54. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Ambrosone CB, McCullough MJ, Ahn J,
Stevens VL, Thun MJ and Hong CC: Oxidative stress-related
genotypes, fruit and vegetable consumption and breast cancer risk.
Carcinogenesis. 30:777–784. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ishikawa M, Kajimura M, Adachi T, Maruyama
K, Makino N, Goda N, Yamaguchi T, Sekizuka E and Suematsu M: Carbon
monoxide from heme oxygenase-2 is a tonic regulator against
NO-dependent vasodilatation in the adult rat cerebral
microcirculation. Circ Res. 97:e104–e114. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vashist YK, Uzungolu G, Kutup A, Gebauer
F, Koenig A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki JR,
et al: Heme oxygenase-1 germ line GTn promoter polymorphism is an
independent prognosticator of tumor recurrence and survival in
pancreatic cancer. J Surg Oncol. 104:305–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bouche D, Chauveau C, Roussel JC, Mathieu
P, Braudeau C, Tesson L, Soulillou JP, Iyer S, Buelow R and Anegon
I: Inhibition of graft arteriosclerosis development in rat aortas
following heme oxygenase-1 gene transfer. Transpl Immunol.
9:235–238. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hadzijusufovic E, Rebuzzi L, Gleixner KV,
Ferenc V, Peter B, Kondo R, Gruze A, Kneidinger M, Krauth MT and
Mayerhofer M: Targeting of heat-shock protein 32/heme oxygenase-1
in canine mastocytoma cells is associated with reduced growth and
induction of apoptosis. Exp Hematol. 36:1461–1470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maines MD and Abrahamsson PA: Expression
of heme oxygenase-1 (HSP32) in human prostate: Normal,
hyperplastic, and tumor tissue distribution. Urology. 47:727–733.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li YX, Li G, Dong WP, Chen J, Wang YF,
Chen XB, Lu DR and Tan JM: Transduction of heme oxygenase-1 gene to
human Islet cells via adenovirus vector enhances anti-apoptosis
function and insulin release. Zhonghua Yi Xue Za Zhi. 86:915–918.
2006.(In Chinese). PubMed/NCBI
|
|
41
|
Nemeth Z, Li M, Csizmadia E, Döme B,
Johansson M, Persson JL, Seth P, Otterbein L and Wegiel B: Heme
oxygenase-1 in macrophages controls prostate cancer progression.
Oncotarget. 6:33675–33688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chau LY: Heme oxygenase-1: Emerging target
of cancer therapy. J Biomed Sci. 22:222015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nitti M, Piras S, Marinari UM, Moretta L,
Pronzato MA and Furfaro AL: HO-1 induction in cancer progression: A
matter of cell adaptation. Antioxidants. 6:62017. View Article : Google Scholar
|
